Search the Newsreel

Why ADMA Biologics (ADMA) Is Up 5.6% After Reaffirming 2026 Revenue Guidance And EPS Momentum

ADMA Biologics reaffirmed its full-year 2026 revenue guidance of US$530 million to US$560 million after reporting solid Q2 2026 results. The company's performance, including higher quarterly and year-to-date EPS, indicates management confidence despite a previous, more bullish guidance reset. The article highlights the importance …

What Archer-Daniels-Midland (ADM)'s Biofuels-Driven Beat and New Debt Issue Means For Shareholders

Archer-Daniels-Midland (ADM) reported strong Q2 2026 results driven by biofuels and oilseed processing, with sales of US$22,681 million and net income of US$908 million. The company also issued US$1.00 billion in new fixed-rate notes and declared a US$0.52 dividend. This performance reinforces ADM's investment …

Archer Daniels Midland raises $1B in dual-tranche notes offering

Archer Daniels Midland (NYSE: ADM) successfully raised $1 billion through a dual-tranche public offering of notes. The offering consisted of two equal tranches: $500 million of 4.829% notes due in 2031 and $500 million of 5.269% notes due in 2036. This strategy provides ADM …

ADMA|ADMA Biologics Inc|Price:9.410|Chg%:-0.370

This article provides a detailed overview of ADMA Biologics Inc. (ADMA) stock, including its current price, market performance, key financial figures, and analyst ratings. It also offers technical analysis, company profile, ownership breakdown, and related instruments in the pharmaceutical sector.

Archer Daniels Midland (ADM) Earnings Date and Reports 2026 $ADM

Can Asceniv Help ADMA Stock Combat IG Market Challenges?

ADMA Biologics ADMA is a U.S.-based commercial-stage biopharmaceutical company focused on developing, manufacturing and marketing specialty biologics for immunodeficient patients and individuals at risk of certain infectious diseases. The company currently markets three FDA-approved plasma-derived biologics: Asceniv (immune globulin intravenous – slra 10% liquid) …

Why Archer Daniels Midland (ADM) Is Back In The Spotlight

Archer-Daniels-Midland (ADM) is gaining attention after reporting strong Q2 sales and net income, alongside plans to expand North American oilseed crush capacity for renewable fuels. The company has seen a significant 35% year-to-date stock gain and a 37.48% one-year total shareholder return. While currently …

Archer Daniels Midland Announces Planned Board Director Transition

Archer Daniels Midland (ADM) announced the planned transition of board director Lei Z. Schlitz, effective December 31, 2026, due to a material change in her employment, not any operational disagreement. This move aligns with the company's corporate governance guidelines, ensuring an orderly board composition …

Wedge Capital Management L L P NC Takes Position in Archer Daniels Midland Company $ADM

Wedge Capital Management L L P NC has initiated a new position in Archer Daniels Midland Company (NYSE:ADM) by purchasing 88,490 shares valued at approximately $6.76 million. This move comes as other institutional investors have also adjusted their stakes in ADM, which reported strong …

Archer-Daniels-Midland’s Q2 Earnings Call: Our Top 5 Analyst Questions

Archer-Daniels-Midland's Q2 Earnings Call: Our Top 5 Analyst Questions Archer-Daniels-Midland's second quarter saw a positive market reaction as the company outperformed Wall Street's expectations on both revenue and profit. Management attributed this performance to robust operational execution, notably in biofuels and oilseed processing, as …

ADMA Tumbles On Slashed Outlook As Short-Seller Aftermath Meets Competitive Headwinds

ADMA Biologics: The Earnings Reset Still Leaves More Upside (NASDAQ:ADMA)

Archer-Daniels-Midland director Lei Z. Schlitz to step down at year-end

Archer-Daniels-Midland Co. announced that director Lei Z. Schlitz will resign from its board, effective December 31, 2026, due to a voluntary change in her principal employment. The company stated that her decision was not due to any disagreement with its operations, policies, or practices. …

Lei Z. Schlitz to Resign from Archer-Daniels-Midland Board, Effective Dec 31, 2026

Archer-Daniels-Midland (ADM) has accepted the resignation of Lei Z. Schlitz from its board of directors, effective December 31, 2026. Schlitz will remain on the board until year-end. The reason for her resignation is a voluntary material change in her principal employment.

Form 8K Archer Daniels Midland For: 12 August By Investing.com

This article announces the filing of a Form 8K by Archer Daniels Midland (ADM) on August 12. It is a brief report from Investing.com, likely indicating a significant event or change for the company that warrants disclosure.

Royal Bank Of Canada Issues Positive Forecast for Admiral Group (LON:ADM) Stock Price

Is Archer-Daniels-Midland (ADM) A Bargain Or Fully Priced Now?

Archer-Daniels-Midland (ADM) shows mixed valuation signals, with a Discounted Cash Flow (DCF) model suggesting it's undervalued by 34.1% at $122 per share, while its P/E ratio of 21.9x indicates it's slightly overvalued compared to an earnings-based fair P/E of 18.5x. The company has delivered …

ADM (ADM) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chair of the Board and Chief Executive Officer - Juan Luciano Executive Vice President and Chief Financial Officer - Monish Patolawala Director Investor Relations - Kathryn Walsh Executive …

Archer-Daniels-Midland Company (ADM) latest stock news and headlines

This article provides a compilation of recent news and headlines concerning Archer-Daniels-Midland Company (ADM), including several articles from Zacks and Simply Wall St. Key topics covered are ADM's stock valuation, earnings reports, dividend announcements, and its performance relative to other consumer staples stocks. The …

Bronstein, Gewirtz & Grossman LLC Urges ADMA Biologics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) alleging investor harm due to false and misleading statements made by the company. The lawsuit claims ADMA engaged in an undisclosed related-party transaction, used channel stuffing, and …

Archer Daniels Midland Company $ADM Shares Sold by Sage Capital Advisors llc

Sage Capital Advisors llc significantly reduced its stake in Archer Daniels Midland (ADM) by 50.7% in the second quarter, selling 57,921 shares but still holding 56,415 shares valued at $4.31 million. Despite this, institutional investors collectively own a substantial 78.28% of the company. ADM …

Archer Daniels Midland Company $ADM Shares Sold by PensionDanmark Pensionsforsikringsaktieselskab

PensionDanmark Pensionsforsikringsaktieselskab significantly reduced its stake in Archer Daniels Midland (ADM) by 35.5% in the second quarter, selling 13,200 shares. Despite this reduction, institutional investors collectively hold 78.28% of the company's stock. ADM recently reported strong quarterly earnings, beating analyst estimates with $1.84 EPS …

Royal Bank of Canada Buys 759,984 Shares of ADMA Biologics Inc $ADMA

Royal Bank of Canada significantly increased its stake in ADMA Biologics Inc. by 448.8% in the first quarter, purchasing 759,984 additional shares, bringing its total to 929,326 shares valued at approximately $8.37 million. ADMA Biologics recently reported quarterly EPS of $0.16, meeting expectations, though …

Janus Henderson Group PLC Trims Stock Holdings in ADMA Biologics Inc $ADMA

Janus Henderson Group PLC significantly reduced its stake in ADMA Biologics Inc by 97.5% in the first quarter, selling over 3.8 million shares and retaining 98,261 shares. Despite this, institutional investors still hold 75.68% of ADMA. The company reported in-line EPS but slightly missed …

Archer Daniels Midland Company (NYSE:ADM) Given Average Rating of "Hold" by Analysts

Analysts have assigned Archer Daniels Midland Company (NYSE:ADM) an average "Hold" rating, with a consensus 12-month price target of approximately $79.67. The company recently reported strong quarterly earnings of $1.84 EPS, beating estimates, and revenue of $22.68 billion, up 7.2% year-over-year. Archer Daniels Midland …

Archer-Daniels-Midland issues $1 billion in new notes due 2031 and 2036

Archer-Daniels-Midland (NYSE:ADM) announced the issuance of $1 billion in new notes, comprising $500 million of 4.829% notes due 2031 and $500 million of 5.269% notes due 2036. This offering was made in connection with a previously filed registration statement on Form S-3. The issuance …

Archer Daniels Midland Co. stock outperforms competitors on strong trading day

Archer Daniels Midland Co. (ADM) shares rose 5.09% to $80.49 on Monday, outperforming the broader market which saw slight declines in the S&P 500 and Dow Jones Industrial Average. This gain ended a three-day losing streak for the company's stock.

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

Schall, Brown & Schwartz LLP ("SBS") has announced a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) for alleged securities fraud, reminding investors who purchased shares during the class period (August 9, 2024, to March 25, 2026) to contact the firm regarding lead …

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

Faruqi & Faruqi, LLP has reminded investors of the August 10, 2026 deadline to seek lead plaintiff status in a securities class action lawsuit against ADMA Biologics, Inc. The lawsuit alleges that ADMA Biologics made false and misleading statements, including engaging in an undisclosed …

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP By Application Deadline

Hagens Berman has filed a securities fraud class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) alleging misrepresentations regarding the company's financial condition, revenue recognition, inventory distribution, and business practices. The lawsuit claims that the company engaged in undisclosed related-party transactions and "channel stuffing," …

Archer Daniels Stock: Analyst Estimates & Ratings

Archer Daniels Midland information technology and support center_ ADM is a global food processing corporation By jetcityimage Headquartered in Chicago, Illinois, Archer-Daniels-Midland Company (ADM) plays a major role across the global agricultural and nutrition landscape, connecting local needs with global capabilities to help strengthen …

DEADLINE NEXT WEEK: Hagens Berman Advises ADMA Biologics, Inc. Investors to Contact the Firm Before August 10, 2026

Hagens Berman has filed a securities fraud class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) on behalf of investors. The lawsuit alleges misrepresentations regarding the company's financial condition, revenue recognition, inventory distribution, and business practices, including an undisclosed related party transaction and channel …

ADMA DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

NEW YORK, Aug. 09, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ADMA Biologics, Inc. (NASDAQ: ADMA) between August 9, 2024 and March 25, 2026, both dates inclusive (the “Class Period”), of the …